HTT CRISPR/Cas13d-gene therapy (Locana)

N/A

Report date: 2025/01/26 15:17:14

Base Information

Drug NameHTT CRISPR/Cas13d-gene therapy (Locana)
Drug Alias NameHTT-targeting RCas13d (Locana)RNA-targeting gene therapy (Locana)AAV-RCas13d (Locana)
ClassificationBiologics
Mechanisms of ActionHuntingtin modulators
TargetsHuntingtin
Therapy Area/IndicationsHuntington Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesLocanabio Inc
China Registration ClassN/A

Develop Information

Active CompaniesLocanabio Inc
Inactive CompaniesN/A
Active IndicationsHuntington Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A